These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38369189)

  • 1. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
    Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
    Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the 2023 North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Navigating New Developments in High Grade Sinonasal Neuroendocrine and Neuroectodermal Neoplasms.
    Rooper LM
    Head Neck Pathol; 2023 Jun; 17(2):299-312. PubMed ID: 37184733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinonasal Tumors With Neuroepithelial Differentiation (Olfactory Carcinoma): Delineation of Their Pathologic and Clinical Features With Insights into Their Relationship to Olfactory Neuroblastoma and Sinonasal Carcinoma.
    Rooper LM; Bishop JA; Faquin WC; Foss RD; Gallia GL; Jo VY; Lewis JS; Nishino M; Stelow EB; Thompson LDR; Wenig BM; Westra WH
    Am J Surg Pathol; 2022 Aug; 46(8):1025-1035. PubMed ID: 35420559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
    Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
    Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
    Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
    Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.
    Shah K; Perez-Ordóñez B
    Head Neck Pathol; 2016 Mar; 10(1):85-94. PubMed ID: 26830400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
    Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
    J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
    Glöss S; Jurmeister P; Thieme A; Schmid S; Cai WY; Serrette RN; Perner S; Ribbat-Idel J; Pagenstecher A; Bläker H; Keber U; Stadelmann C; Zechel S; Johann PD; Hasselblatt M; Paulus W; Thomas C; Dohmen H; Baumhoer D; Frank S; Agaimy A; Schüller U; Vasudevaraja V; Snuderl M; Liu CZ; Pfister DG; Jungbluth AA; Ghossein RA; Xu B; Capper D; Dogan S
    Am J Surg Pathol; 2021 Sep; 45(9):1190-1204. PubMed ID: 34265800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine and undifferentiated sinonasal and skull base tumors: An up-to-date narrative review.
    Sideris G; Solomos P; Gogoulos P; Margaris I; Panagoulis E; Vlastarakos P; Karamagkiolas S; Tzagkaroulakis M; Nikolopoulos T; Delides A
    Oral Maxillofac Surg; 2024 Sep; 28(3):1009-1017. PubMed ID: 38502274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
    Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
    Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
    Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
    Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
    Czapiewski P; Kunc M; Haybaeck J
    Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Epstein-Barr virus infection in sinonasal small round cell tumors.
    Shinokuma A; Hirakawa N; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2000 Jan; 126(1):12-8. PubMed ID: 10641744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Loss of SMARCA4 in Sinonasal Teratocarcinosarcoma.
    Rooper LM; Uddin N; Gagan J; Brosens LAA; Magliocca KR; Edgar MA; Thompson LDR; Agaimy A; Bishop JA
    Am J Surg Pathol; 2020 Oct; 44(10):1331-1339. PubMed ID: 32520761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
    Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
    J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.
    Bellizzi AM; Bourne TD; Mills SE; Stelow EB
    Am J Clin Pathol; 2008 Mar; 129(3):367-76. PubMed ID: 18285258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.